Characteristics of clinical trials to support approval of orphan drugs for neurological disorders by the Japanese regulatory agency

被引：0
|
作者：
Nakamura, H. [1 ]
Takeda, S. [2 ]
Iwasaki, M. [3 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Kodaira, Tokyo, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Kodaira, Tokyo, Japan
[3] Univ Yamanashi, Dept Clin Res, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.2385
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2354
引用
收藏
页码：847 / 847
页数：1
相关论文
共 50 条
  • [31] Clinical trial evidence supporting FDA approval of novel orphan drugs between 2017 and 2023
    Chen, Qi
    Xu, Yang
    Qu, Ruoxuan
    Luo, Xingxian
    Yang, Yue
    DRUG DISCOVERY TODAY, 2024, 29 (09)
  • [32] What could gene therapies learn from orphan drugs' post-regulatory approval access in the EU?
    Iskrov, Georgi
    Vasilev, Georgi
    Stefanov, Rumen
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (09): : 407 - 414
  • [33] Clinical trials of coenzyme Q10 in neurological disorders
    Shults, Clifford W.
    Haas, Richard
    BIOFACTORS, 2005, 25 (1-4) : 117 - 126
  • [34] Underregistration and Underreporting of Stem Cell Clinical Trials in Neurological Disorders
    Lee, Timothy E.
    Kim, Aryun
    Jang, Mihee
    Jeon, Beomseok
    JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (02): : 215 - 224
  • [35] Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
    Lui, Austin
    Do, Timothy
    Alzayat, Omar
    Yu, Nina
    Phyu, Su
    Santuya, Hillary Joy
    Liang, Benjamin
    Kailash, Vidur
    Liu, Dewey
    Inslicht, Sabra S.
    Shahlaie, Kiarash
    Liu, DaZhi
    PHARMACEUTICALS, 2024, 17 (04)
  • [36] General characteristics of clinical trials for biosimilar drugs
    Akici, Ahmet
    Vizdiklar, Caner
    MARMARA MEDICAL JOURNAL, 2021, 34 (02): : 89 - 94
  • [37] Time for clinical trials of epigenetic drugs in psychiatric disorders?
    Peedicayil, Jacob
    Kumar, Aniket
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 309 - 310
  • [38] The Evolving Paradigm for Clinical Development and Regulatory Approval of Antiretroviral Drugs in the United States
    David M. Cocchetto
    Lynn Smiley
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 357 - 372
  • [39] The evolving paradigm for clinical development and regulatory approval of antiretroviral drugs in the United States
    Cocchetto, DM
    Smiley, L
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 357 - 372
  • [40] Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
    Nishikawa, Shigeto
    Iwakuma, Tomoo
    CANCERS, 2023, 15 (02)
12345